Revenue $5.06B, up 9.3% on a year earlier. FSS International Sales $1.56B, up 13.3%. FSS North America Sales $3.50B, up 7.7%. Diluted EPS $0.36 against $0.27.
| Q3 FY26 | Q2 FY26 | Q3 FY25 | Year over year | |
|---|---|---|---|---|
| Revenue | $5.06B | $4.91B | $4.63B | +9.3% |
| Operating income | $215.59M | $219.75M | $182.59M | +18.1% |
| Net income | $97.83M | $102.14M | $71.95M | +36.0% |
| Diluted EPS | $0.36 | $0.38 | $0.27 | |
| Operating cash flow | $117.19M | $400.25M | $76.68M | +52.8% |
| Capital expenditures | -$112.37M | -$101.28M | -$111.38M | |
| Free cash flow | $4.82M | $298.98M | -$34.70M | |
| Dividend per share | $0.12 | $0.12 | $0.10 |
| Q3 FY26 | Q3 FY25 | Year over year | |
|---|---|---|---|
| FSS International Sales | $1.56B | $1.38B | +13.3% |
| FSS North America Sales | $3.50B | $3.25B | +7.7% |
| Organic sales growth | 9% | 5% |
The week's biggest guidance misses, KPI surprises and one chart.
Stock Atlas, “Aramark (ARMK) Q3 FY26 earnings: results and KPIs”, stockatlas.com/companies/ARMK/earnings/2026-q3/, data as of 3 November 2026. Links to this page are welcome.
